Product References
Ex vivo assays to predict enhanced chemosensitization by hyperthermia in urothelial cancer of the bladder.
PloS one
van den Tempel N,Naipal KAT,Raams A,van Gent DC,Franckena M,Boormans JL,Kanaar R
Mon May 13 00:00:00 EDT 2019
A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation.
EMBO molecular medicine
Castroviejo-Bermejo M,Cruz C,Llop-Guevara A,Gutiérrez-Enríquez S,Ducy M,Ibrahim YH,Gris-Oliver A,Pellegrino B,Bruna A,Guzmán M,Rodríguez O,Grueso J,Bonache S,Moles-Fernández A,Villacampa G,Viaplana C,Gómez P,Vidal M,Peg V,Serres-Créixams X,Dellaire G,Simard J,Nuciforo P,Rubio IT,Dienstmann R,Barrett JC,Caldas C,Baselga J,Saura C,Cortés J,Déas O,Jonkers J,Masson JY,Cairo S,Judde JG,O'Connor MJ,Díez O,Balmaña J,Serra V
Sat Dec 01 00:00:00 EST 2018
BRCA1 Mutation-Specific Responses to 53BP1 Loss-Induced Homologous Recombination and PARP Inhibitor Resistance.
Cell reports
Nacson J,Krais JJ,Bernhardy AJ,Clausen E,Feng W,Wang Y,Nicolas E,Cai KQ,Tricarico R,Hua X,DiMarcantonio D,Martinez E,Zong D,Handorf EA,Bellacosa A,Testa JR,Nussenzweig A,Gupta GP,Sykes SM,Johnson N
Tue Sep 25 00:00:00 EDT 2018
Combined B, T and NK Cell Deficiency Accelerates Atherosclerosis in BALB/c Mice.
PloS one
Cheng F,Twardowski L,Reifenberg K,Winter K,Canisius A,Pross E,Fan J,Schmitt E,Shultz LD,Lackner KJ,Torzewski M
Tue Aug 08 00:00:00 EDT 2017
Cumulative defects in DNA repair pathways drive the PARP inhibitor response in high-grade serous epithelial ovarian cancer cell lines.
Oncotarget
Fleury H,Carmona E,Morin VG,Meunier L,Masson JY,Tonin PN,Provencher D,Mes-Masson AM
Tue Jun 20 00:00:00 EDT 2017
APC/CCDC20 and APC/C play pivotal roles in the process of embryonic development in Artemia sinica.
Scientific reports
Zhang M,Yao F,Luan H,Zhao W,Jing T,Zhang S,Hou L,Zou X
Mon Dec 19 00:00:00 EST 2016
In Vivo Stabilization of a Gastrin-Releasing Peptide Receptor Antagonist Enhances PET Imaging and Radionuclide Therapy of Prostate Cancer in Preclinical Studies.
Theranostics
Chatalic KL,Konijnenberg M,Nonnekens J,de Blois E,Hoeben S,de Ridder C,Brunel L,Fehrentz JA,Martinez J,van Gent DC,Nock BA,Maina T,van Weerden WM,de Jong M
Thu Oct 06 00:00:00 EDT 2016
Delayed DNA double-strand break repair following platin-based chemotherapy predicts treatment response in head and neck squamous cell carcinoma.
British journal of cancer
Bhide SA,Thway K,Lee J,Wong K,Clarke P,Newbold KL,Nutting CM,Harrington KJ
Tue Sep 27 00:00:00 EDT 2016
Hyperthermia Synergizes with Chemotherapy by Inhibiting PARP1-Dependent DNA Replication Arrest.
Cancer research
Schaaf L,Schwab M,Ulmer C,Heine S,Mürdter TE,Schmid JO,Sauer G,Aulitzky WE,van der Kuip H
Sun May 15 00:00:00 EDT 2016
The BRCA1-Δ11q Alternative Splice Isoform Bypasses Germline Mutations and Promotes Therapeutic Resistance to PARP Inhibition and Cisplatin.
Cancer research
Wang Y,Bernhardy AJ,Cruz C,Krais JJ,Nacson J,Nicolas E,Peri S,van der Gulden H,van der Heijden I,O'Brien SW,Zhang Y,Harrell MI,Johnson SF,Candido Dos Reis FJ,Pharoah PD,Karlan B,Gourley C,Lambrechts D,Chenevix-Trench G,Olsson H,Benitez JJ,Greene MH,Gore M,Nussbaum R,Sadetzki S,Gayther SA,Kjaer SK,D'Andrea AD,Shapiro GI,Wiest DL,Connolly DC,Daly MB,Swisher EM,Bouwman P,Jonkers J,Balmaña J,Serra V,Johnson N
Sun May 01 00:00:00 EDT 2016
Cell cycle and apoptosis regulatory proteins, proliferative markers, cell signaling molecules, CD209, and decorin immunoreactivity in low-grade myxofibrosarcoma and myxoma.
Virchows Archiv : an international journal of pathology
Cates JM,Memoli VA,Gonzalez RS
Sat Aug 01 00:00:00 EDT 2015
Whole genomes redefine the mutational landscape of pancreatic cancer.
Nature
Waddell N,Pajic M,Patch AM,Chang DK,Kassahn KS,Bailey P,Johns AL,Miller D,Nones K,Quek K,Quinn MC,Robertson AJ,Fadlullah MZ,Bruxner TJ,Christ AN,Harliwong I,Idrisoglu S,Manning S,Nourse C,Nourbakhsh E,Wani S,Wilson PJ,Markham E,Cloonan N,Anderson MJ,Fink JL,Holmes O,Kazakoff SH,Leonard C,Newell F,Poudel B,Song S,Taylor D,Waddell N,Wood S,Xu Q,Wu J,Pinese M,Cowley MJ,Lee HC,Jones MD,Nagrial AM,Humphris J,Chantrill LA,Chin V,Steinmann AM,Mawson A,Humphrey ES,Colvin EK,Chou A,Scarlett CJ,Pinho AV,Giry-Laterriere M,Rooman I,Samra JS,Kench JG,Pettitt JA,Merrett ND,Toon C,Epari K,Nguyen NQ,Barbour A,Zeps N,Jamieson NB,Graham JS,Niclou SP,Bjerkvig R,Grützmann R,Aust D,Hruban RH,Maitra A,Iacobuzio-Donahue CA,Wolfgang CL,Morgan RA,Lawlor RT,Corbo V,Bassi C,Falconi M,Zamboni G,Tortora G,Tempero MA,Gill AJ,Eshleman JR,Pilarsky C,Scarpa A,Musgrove EA,Pearson JV,Biankin AV,Grimmond SM
Thu Feb 26 00:00:00 EST 2015
Cell cycle kinetic analysis of colorectal neoplasms using a new automated immunohistochemistry-based cell cycle detection method.
Medicine
Tomono A,Itoh T,Yanagita E,Imagawa N,Kakeji Y
Thu Jan 01 00:00:00 EST 2015
Functional ex vivo assay to select homologous recombination-deficient breast tumors for PARP inhibitor treatment.
Clinical cancer research : an official journal of the American Association for Cancer Research
Naipal KA,Verkaik NS,Ameziane N,van Deurzen CH,Ter Brugge P,Meijers M,Sieuwerts AM,Martens JW,O'Connor MJ,Vrieling H,Hoeijmakers JH,Jonkers J,Kanaar R,de Winter JP,Vreeswijk MP,Jager A,van Gent DC
Mon Sep 15 00:00:00 EDT 2014
A marker of homologous recombination predicts pathologic complete response to neoadjuvant chemotherapy in primary breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research
Graeser M,McCarthy A,Lord CJ,Savage K,Hills M,Salter J,Orr N,Parton M,Smith IE,Reis-Filho JS,Dowsett M,Ashworth A,Turner NC
Wed Dec 15 00:00:00 EST 2010